Androgen deficiency in the aging male

Fertility and Sterility

Volumn 90, Issue 5 SUPPL., 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GONADOTROPIN; LUTEINIZING HORMONE; PRASTERONE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PELLET; UNCLASSIFIED DRUG;

AGING; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DRUG DOSE ESCALATION; DRUG EFFICACY; GONADOTROPIN BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPOGONADISM; INFECTION; LABORATORY TEST; LIPOPROTEIN LEVEL; LIVER FUNCTION; LIVER TOXICITY; LUTEINIZING HORMONE BLOOD LEVEL; MOOD CHANGE; PAIN; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL;

AGING; ANDROGENS; HEALTH PLANNING GUIDELINES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MONITORING, PHYSIOLOGIC;

EID: 55449118179     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.094     Document Type: Article

References (42)

1. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone in healthy men. J Clin Endocrinol Metab 86 (2001) 724-731
2. Arujo A.B., O'Donnell A.B., Brambilla D.J., Simpson W.B., Longcope C., Matsumoto A.M., and McKinlay J.B. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89 (2004) 5920-5926
3. Swerdloff R.S. Proceedings of the Endocrine Society Andropause Consensus Conferences 2000-2001. Continuing Medical Education Series. Chevy Chase, MD: The Endocrine Society (2002)
4. Morales A., and Lunenfeld B. Standards, guidelines, and recommendations of the International Society for the Study of the Aging Male (ISSAM): androgen replacement therapy in aging men with secondary hypogonadism. Aging Male 4 (2001) 151-162
5. Liu P.Y., Swerdloff R.S., and Veldhuis J.D. Clinical review 171. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89 (2004) 4789-4796
6. Lunenfeld B., Saad F., and Hoesl C.E. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male 8 (2005) 59-74
7. Report of National Institute on Aging advisory panel on testosterone replacement in men. J Clin Endocrinol Metab 86 (2001) 461-464
8. Tan R.S., and Culberson J.W. An integrative review on current evidence of testosterone replacement therapy for the treatment of andropause. Maturitas 45 (2003) 15-27
9. Hijazi R.A., and Cunningham G.R. Andropause: Is androgen replacement therapy indicated for the aging male?. Annu Rev Med 56 (2005) 117-137
10. T'Sjoen G., and Kaufman J.M. Androgen deficiency in aging men. Curr Opin Endocrinol Diabetes Obes 13 (2006) 254-261
11. Korenman S.G., Morley J.E., Mooradian A.D., Davis S.S., Kaiser F.E., Silver A.J., et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 71 (1990) 963-969
12. van den Beld A.W., de Jong F.H., Grobbee D.E., Pols H.A., and Lamberts S.W. Measures of bioavailable serum testosterone and estradiol and their relationship with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85 (2000) 3276-3282
13. Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am J Psychiatry 155 (1998) 1310-1318
14. Janowsky J.S., Oviatt S.K., and Orwoll E.S. Testosterone influences spatial cognition in older men. Behav Neurosci 108 (1994) 325-332
15. Greendale G., Edelstein S., and Barrett-Connor E. Endogenous sex steroid and bone mineral density in older women and men (the Rancho Bernardo Study). J Bone Miner Res 12 (1997) 1833-1843
16. Vermeulen A., Goemaere S., and Kaufman J.M. Sex hormones, body composition, and aging. Aging Male 2 (1999) 8-15
17. Turner H.E., and Wass J.A. Gonadal function in men with chronic illness. Clin Endocrinol 47 (1997) 379-403
18. Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., Skinner J.S., et al. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab 85 (2000) 1026-1031
19. Morley J.E., Charlton E., Patrick P., Kaiser F.E., Cadeau P., McCready D., et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49 (2000) 1239-1242
20. Smith K.W., Feldman H.A., and McKinlay J.B. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocriol 53 (2000) 703-711
21. Heinemann L.A.J., Saad F., Thiele K., and Wood-Dauphinee S. The aging males' symptoms rating scale: cultural and linguistic validation into English. Aging Male 4 (2001) 14-22
22. T'Sjoen G., Goemaere S., De Meyere M., and Kaufman J.-M. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 29 (2004) 201-214
23. Tancredi A., Reginster J.-Y., Schleich F., Pire G., Maassen P., Luyckx F., and Legros J.-J. Interest of the Androgen Deficiency in Aging Males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 151 (2004) 355-360
24. Mosely J.E., Perry III H.M., Kevorkian R.T., and Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 53 (2006) 424-429
25. Lin Y.C., Hwang T.I.S., Chiang H.S., Yang C.R., WU H.C., Wu T.L., and Huang S.P. Correlations of androgen deficiency with clinical symptoms in Taiwanese males. Int J Impot.Res 18 (2006) 343-347
26. Nilsson P., Moller L., and Solstad K. Adverse effects of psychosocial stress on gonadal function and insulin levels in middle aged males. J Intern Med 237 (1995) 479-486
27. Moffat S.D., Zonderman A.B., Metter E.J., Blackman M.R., Harman S.M., and Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87 (2002) 5001-5007
28. Mohr B.A., Bhasin S., Link C.L., O'Donnell A.B., and McKinlay J.B. The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol 155 (2006) 443-452
29. Vermeulen A., Verdonck L., and Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84 (1999) 3666-3672
30. Khosla S., Melton III L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., and Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men: a key role for bio-available estrogen. J Clin Endocrinol Metab 83 (1998) 2266-2274
31. Liu P.Y., Swerdloff R.S., and Veldhuis J.D. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89 (2004) 4789-4796
32. Morales A.J., Nolan J.J., Nelson J.C., and Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78 (1994) 1360-1367
33. Bhasin S., Singh A.B., Mac R.P., Carter B., Lee M.I., and Cunningham G.R. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl 24 (2003) 299-311
34. Matsumoto A.M., Sandblom R.E., Schoene R.B., Lee K.A., Giblin E.C., Pierson D.J., et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol 22 (1985) 713-721
35. Hak A.E., Witteman J.C., de Jong F.H., Geerlings M.I., Hofman A., and Pols H.A. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men; the Rotterdam Study. J Clin Endocrinol Metab 87 (2002) 3632-3639
36. Kupelian V., Page S.T., Araujo A.B., Travison T.G., Bremner W.J., and McKinlay J.B. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91 (2006) 843-850
37. Webb C.M., McNeill J.G., Hayward C.S., de Zeigler D., and Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 100 (1999) 1690-1696
38. Webb C.M., Adamson D.L., de Zeigler D., and Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 83 (1999) 437-439
39. Liu P.Y., Death D.K., and Handelsman D.J. Androgens and cardiovascular disease. Endocrinol Rev 24 (2003) 313-340
40. Wu F.C.W., and von Eckardstein A. Androgens and coronary artery disease. Endocrinol Rev 24 (2003) 183-217
41. Tenover J.S. Experience with testosterone replacement in the elderly. Mayo Clin Proc 75 Suppl (2000) S77-S82
42. Morgentaler A., Bruning III C.O., and DeWolf W.C. Occult prostate cancer in men with low serum testosterone levels. JAMA 276 (1996) 1904-1906